Chicken Anti-SARS-CoV S Recombinant Antibody (clone 4S1)

CAT#: VS-0323-CJ47

This chicken anti-SARS-CoV S antibody (clone 4S1) is a product that recognizes SARS-CoV S proteins.

Published Data
Figure 1 Binding activity of randomly chosen phages from library 4S after the fourth panning cycle. Figure 2 Binding activity of 4S1 phage binder to native S protein. Figure 3 Epitope mapped by 4S1 phage binder.

Specifications

  • Immunogen
  • Recombinant S proteins
  • Host Species
  • Chicken
  • Type
  • Chicken IgY
  • Specificity
  • SARS-CoV S proteins
  • Species Reactivity
  • SARS-CoV
  • Clone
  • 4S1
  • Applications
  • Enzyme-linked Immunosorbent Assay, Western Blot, Immunofluorescence
  • Conjugate
  • Unconjugated
  • Related Disease
  • Severe acute respiratory syndrome (SARS)

Product Property

  • Purity
  • >95% as determined by SDS-PAGE
  • Buffer
  • PBS
  • Storage
  • Store at 4°C for short term. Aliquot and store at -20°C for long term. Avoid repeated freeze/thaw cycles.

Applications

  • Application Notes
  • The Phage clone of this antibody exhibited significant binding activity (OD between 0.7 and 1.2) to SARS-CoV S protein. Phage 4S1 bind to SARS-CoV-infected Vero E6 cells, whose binding activity is comparable to that of convalescent patient serum.

Target

  • Alternative Names
  • E2
  • Sequence Similarities
  • Belongs to the betacoronaviruses spike protein family.
  • Cellular Localization
  • Host cell membrane; Host membrane; Membrane; Viral envelope protein; Virion
  • Post Translation Modifications
  • The cytoplasmic Cys-rich domain is palmitoylated. Spike glycoprotein is digested by cathepsin CTSL within endosomes.
    Specific enzymatic cleavages in vivo yield mature proteins. The precursor is processed into S1 and S2 by host cell furin or another cellular protease to yield the mature S1 and S2 proteins. Additionally, a second cleavage leads to the release of a fusion peptide after viral attachment to host cell receptor.
    The cytoplasmic Cys-rich domain is palmitoylated. Spike glycoprotein is digested within host endosomes.
  • Function
  • Spike glycoprotein: May down-regulate host tetherin (BST2) by lysosomal degradation, thereby counteracting its antiviral activity.
    Spike protein S1: Attaches the virion to the cell membrane by interacting with host receptor, initiating the infection. Binding to human ACE2 and CLEC4M/DC-SIGNR receptors and internalization of the virus into the endosomes of the host cell induces conformational changes in the S glycoprotein. Proteolysis by cathepsin CTSL may unmask the fusion peptide of S2 and activate membrane fusion within endosomes.
    Spike protein S2: Mediates fusion of the virion and cellular membranes by acting as a class I viral fusion protein. Under the current model, the protein has at least three conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and target cell membrane fusion, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes.
    Spike protein S2': Acts as a viral fusion peptide which is unmasked following S2 cleavage occurring upon virus endocytosis.
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for VS-0323-CJ47. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

Isotype Control

Secondary Antibody

Recommended Dilution Buffer

See other products for "SARS-CoV S"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
EPAF-1139CQ Recombinant Human Anti-SARS-CoV S Antibody (m396) ELISA IgG1
CAT Product Name Application Type
NAB-474CQ Camelid Anti-SARS-CoV S Recombinant Single Domain Antibody (NAB-474CQ) Neut Camelid VHH
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare